<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30329</article-id><article-id pub-id-type="doi">10.7554/eLife.30329</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>Distinct cellular and molecular mechanisms for β3 adrenergic receptor induced beige adipocyte formation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-92950"><name><surname>Jiang</surname><given-names>Yuwei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-92626"><name><surname>Berry</surname><given-names>Daniel C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5200-1182</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-9368"><name><surname>Graff</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Division of Endocrinology, Department of Internal Medicine</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1193"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Los Angeles</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dcb37@cornell.edu</email> (DB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>jon.graff@utsouthwestern.edu</email> (JG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>10</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e30329</elocation-id><history><date date-type="received"><day>11</day><month>07</month><year>2017</year></date><date date-type="accepted"><day>05</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Jiang et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Jiang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-30329-v1.pdf"/><abstract><p>Beige/brite adipocytes are induced within white adipose tissues (WAT) and, when activated, consume glucose and fatty acids to produce heat. Classically, two stimuli have been used to trigger a beiging response: cold temperatures and β3-adrenergic receptor (<italic>Adrb3</italic>) agonists. These two beiging triggers have been used interchangeably but whether these two stimuli may induce beiging differently at cellular and molecular levels remains unclear. Here we found that cold-induced beige adipocyte formation requires <italic>Adrb</italic>1, not <italic>Adrb3</italic>, activation. <italic>Adrb</italic>1 activation stimulates WAT resident perivascular (<italic>Acta2</italic>+) cells to form cold-induced beige adipocytes. In contrast, <italic>Adrb3</italic> activation stimulates mature white adipocytes to convert into beige adipocytes. Necessity tests, using mature adipocyte specific <italic>Prdm16</italic> deletion strategies, demonstrated that adipocytes are a required and are a predominant source to generate <italic>Adrb3</italic>-induced, but not cold-induced, beige adipocytes. Collectively, we identify that cold temperatures and <italic>Adrb3</italic> agonists activate distinct cellular populations that express different β-adrenergic receptors to induce beige adipogenesis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>K01 DK109027</award-id><principal-award-recipient><name><surname>Berry</surname><given-names>Daniel C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>K01 DK111771</award-id><principal-award-recipient><name><surname>Jiang</surname><given-names>Yuwei</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK088220</award-id><principal-award-recipient><name><surname>Graff</surname><given-names>John</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK064261</award-id><principal-award-recipient><name><surname>Graff</surname><given-names>John</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK066556</award-id><principal-award-recipient><name><surname>Graff</surname><given-names>John</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>John Graff, is a co-founder and shareholder of Reata Pharmaceuticals. Reata Pharmaceuticals has no financial interest in this study.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animals were maintained under the approved protocols and ethical guidelines of the UT Southwestern Medical Center Animal Care and Use Committee under the protocol number 2016--101336.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-30329-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>